论文部分内容阅读
目的:评价我国期刊发表的皮肤疾病临床指南的报告质量。方法:计算机检索中国知网、维普医药、万方医学、中国生物医药数据库，检索日期为2009年1月至2019年10月，收集在我国期刊上公开发表的皮肤疾病临床指南。由2位评价员独立筛选文献，提取资料并交叉核对。使用临床实践指南报告标准（RIGHT）评价指南质量，采用Excel 2017对数据进行统计分析。结果:共纳入17篇皮肤疾病临床指南，包括13篇西医指南和4篇中医指南。13篇西医指南中，RIGHT标准的7个评价领域即基本信息、背景、证据、推荐意见、评审和质量保证、资助与利益冲突、其他方面的报告篇数分别为9、6、0、4、0、1、1；4篇中医指南中，上述领域报告篇数分别为4、3、3、3、3、2、2。结论:近10年我国期刊发表的皮肤疾病临床指南总体报告质量具有较大进步空间，建议在以后指南制订过程中参考RIGHT规范加强报告质量。“,”Objective:To evaluate the reporting quality of clinical guidelines on skin diseases published in journals in China.Methods:The CNKI, VIP, Wanfang and SinoMed databases were searched from January 2009 to October 2019 for clinical guidelines on skin diseases published in journals in China. Two reviewers independently screened the literature, and extracted and cross-checked data. The reporting quality of these clinical guidelines was evaluated by using the Reporting Items for Practice Guidelines in Healthcare (RIGHT) , and statistical analysis was carried out with Excel 2017 software.Results:A total of 17 clinical guidelines on skin diseases were included, including 13 Western medicine guidelines and 4 Chinese medicine guidelines. Among the 13 Western medicine guidelines, the number of guidelines reporting the following areas in the RIGHT statement, namely basic information, background, evidence, recommendations, review and quality assurance, funding and declaration and management of interests, and other information, was 9, 6, 0, 4, 0, 1 and 1 respectively; among the 4 Chinese medicine guidelines, the number of guidelines reporting the above 7 areas in the RIGHT statement was 4, 3, 3, 3, 3, 2 and 2 respectively.Conclusion:There is still considerable room for improvement in the overall reporting quality of clinical guidelines on skin diseases published in journals in China during the past 10 years, and the RIGHT statement is recommended for improving the reporting quality in guideline development.